Researchers have found that the cost of preventive antibiotic tuberculosis therapy for patients infected by human immunodeficiency virus is generally less expensive than the reported cost of treating newly confirmed TB cases.
Researchers have found that the cost of preventive antibiotic tuberculosis therapy for patients infected by human immunodeficiency virus is generally less expensive than the reported cost of treating newly confirmed TB cases.